QQ客服 官方微博 反馈留言

	Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer
	Yang, Juan; Li, Guiyuan*; Zhang, Keqiang
刊名	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
	2016
卷号	84页码:1078-1087
关键词	DR4 DR5 Six1 GALNT14 Survival and apoptotic signals
ISSN号	0753-3322
DOI	10.1016/j.biopha.2016.10.028
URL标识	查看原文
WOS记录号	WOS:000390438100125;PMID:27780136
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3340691
专题	中南大学
作者单位	[Yang, Juan] Cent S Univ, Xiangya Sch Med, Affiliated Canc Hosp, Hunan Canc Hosp, 126 Xian Jia Hu Rd, Changsha 410006, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Yang, Juan,Li, Guiyuan*,Zhang, Keqiang. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer[J]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2016,84:1078-1087.
APA	Yang, Juan,Li, Guiyuan*,&Zhang, Keqiang.(2016).Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,84,1078-1087.
MLA	Yang, Juan,et al."Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer".Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 84(2016):1078-1087.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。